ID4 Gene: A Potential Drug Target for IL-8 (G3394)

Target Name: IRF8

NCBI ID: G3394

IRF8

ID4 Gene: A Potential Drug Target for IL-8

The interleukin-8 (IL-8) gene is a key regulator of inflammatory responses and has been implicated in a wide range of diseases, including autoimmune disorders, cancer, and neurodegenerative diseases. The protein produced by the IL-8 gene, Interleukin-8 (IL-8), is a cytokine that plays a critical role in the regulation of immune and inflammatory responses. Despite the significant impact of IL-8 on human health, the underlying molecular mechanisms that regulate its function are not well understood.

The ID4 gene, which encodes the IL-8 receptor, has been identified as a potential drug target for the treatment of various diseases. The ID4 gene is a single-pass transmembrane protein that is expressed in many different tissues and cells, including immune cells, epithelial cells, and nervous cells. The ID4 gene has been shown to be involved in the regulation of cellular processes that are important for tissue repair, regeneration, and inflammation.

IRF8: A Potential Drug Target for IL-8

The ID4 gene has been shown to be involved in the regulation of IL-8 signaling, which is a critical pathway in the regulation of immune and inflammatory responses. IL-8 is a cytokine that is produced by various cell types in response to inflammation or infection, and it has been shown to play a critical role in the regulation of immune responses, including the regulation of inflammation and the recruitment of immune cells to the site of infection or injury.

The ID4 gene has been shown to be involved in the regulation of IL-8 signaling by producing the ID4 protein, which is a critical component of the IL-8 receptor. The ID4 protein has been shown to play a critical role in the regulation of cellular processes that are important for tissue repair, regeneration, and inflammation.

Studies have shown that the ID4 gene is involved in the regulation of various cellular processes that are important for tissue repair and regeneration, including the regulation of cell proliferation, the production of extracellular matrix (ECM) components, and the regulation of cell adhesion. The ID4 gene has also been shown to be involved in the regulation of inflammation, including the regulation of immune cell function and the production of pro-inflammatory cytokines.

In addition to its role in the regulation of IL-8 signaling, the ID4 gene has also been shown to be involved in the regulation of various cellular processes that are important for tissue regeneration and repair. The ID4 gene has been shown to be involved in the regulation of cell proliferation, including the regulation of cell cycle progression and the production of new cells. The ID4 gene has also been shown to be involved in the regulation of cell adhesion, including the regulation of cell-cell adhesion and the regulation of cell-permeable vesicles (PMVs).

The ID4 gene has also been shown to be involved in the regulation of various cellular processes that are important for tissue regeneration and repair, including the regulation of cell proliferation, the production of ECM components, and the regulation of cell adhesion.

Despite the significant impact of the ID4 gene on cellular processes important for tissue repair and regeneration, the underlying molecular mechanisms that regulate its function are not well understood. Further research is needed to fully understand the role of the ID4 gene in the regulation of IL-8 signaling and the potential therapeutic applications of targeting the ID4 gene.

Conclusion

The ID4 gene has been shown to be involved in the regulation of various cellular processes that are important for tissue repair and regeneration, including the regulation of cell proliferation, the production of ECM components, and the regulation of cell adhesion. The ID4 gene has also been shown to be involved in the regulation of IL-8 signaling, which is a critical pathway in the regulation of immune and inflammatory responses.

The potential therapeutic applications of targeting the ID4 gene are vast and range from the treatment of

Protein Name: Interferon Regulatory Factor 8

Functions: Transcription factor that specifically binds to the upstream regulatory region of type I interferon (IFN) and IFN-inducible MHC class I genes (the interferon consensus sequence (ICS)) (PubMed:25122610). Can both act as a transcriptional activator or repressor (By similarity). Plays a negative regulatory role in cells of the immune system (By similarity). Involved in CD8(+) dendritic cell differentiation by forming a complex with the BATF-JUNB heterodimer in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF8 and activation of genes (By similarity). Required for the development of plasmacytoid dendritic cells (pDCs), which produce most of the type I IFN in response to viral infection (By similarity). Positively regulates macroautophagy in dendritic cells (PubMed:29434592)

The "IRF8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IRF8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets